Patents by Inventor Remi Urbain

Remi Urbain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF ANTI-CD20 ANTIBODY FOR TREATING PRIMARY INTRAOCULAR LYMPHOMA
    Publication number: 20120100133
    Abstract: An embodiment relates to a monoclonal antibody directed against the CD20 antgen, in which the variable region of each of the light chains is coded by murine nucleic acid sequence SEQ ID NO:1, the variable region of each of the heavy chains is coded by murine nucleic acid sequence SEQ ID NO: 2, and the constant regions of the light chains and of the heavy chains originate from a non-murine species, said antibody being used for treating primary intraocular lymphoma.
    Type: Application
    Filed: November 26, 2009
    Publication date: April 26, 2012
    Applicant: LFB BIOTECHNOLOGIES
    Inventors: Sylvain Fisson, Catherine Fridman, Remi Urbain